ScholarIQanswers from OpenAlex

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018

PaperCitations, authors & open-access status

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 have?

ScholarIQcitation count

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 has 391 citations in the OpenAlex counts ScholarIQ stores.

When was NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 published?

ScholarIQyear

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 has 2018 year in the ScholarIQ index.

What is the open-access status of NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018?

ScholarIQoa status

NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 has bronze oa status in the ScholarIQ index.

What is the DOI of NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018?

ScholarIQdoi

The DOI for NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 is on the source record.

What is the PMID of NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018?

ScholarIQpmid

The PMID for NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 is on the source record.

What is the OpenAlex record for NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018?

ScholarIQopenalex

The OpenAlex for NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial